ATS 2020 Advance Program

9:57 Limited Resources, High Quality: Treating Respiratory Failure and Shock in Ethiopian EDs and Wards H.Y. Ahmed, MD, MPH, Addis Ababa, Ethiopia 10:09 Ordering Chaos: Critical Care Delivery During Disasters and Epidemics E.L. Daugherty, MD, MPH, Baltimore, MD 10:21 Panel Discussion: Scoop and Run or Stay and Play? Debating Critical Care Delivery Models I. Peltan, MD, MSc, Murray, UT TRANSLATIONAL SCIENTIFIC SYMPOSIUM D5 MICROBIOME-IMMUNE INTERACTIONS IN ASTHMA Assemblies on Allergy, Immunology and Inflammation; Pediatrics 8:45 a.m. - 10:45 a.m. Target Audience Trainees, clinicians, researchers, allied health personnel Objectives At the conclusion of this session, the participant will be able to: • learn new findings about the interaction between the microbiome, immune development, and asthma exacerbations; • describe methods to alter the microbiome to prevent asthma; • obtain new skills to interpret literature on the microbiome and asthma. While numerous studies have described bacteria detected in the airway of patients with asthma, it remains unclear if these microbes contribute to asthma development and asthma exacerbations. This session will highlight recent research focused on the interaction between the microbiome, immune development, and asthma exacerbations, and will address ways to alter the microbiome to prevent asthma. Chairing: K.M. Kloepfer, MD, MS, Indianapolis, IN Y.J. Huang, MD, Ann Arbor, MI 8:45 Environment, Genetics and Microbial-Immune Interactions in Pediatric Asthma E. von Mutius, MD, MSc, Muenchen, Germany 9:10 The Role of the Nasal Microbiome in Asthma Risk and Exacerbations J.E. Gern, MD, Madison, WI 9:35 Gut Microbiota-Immune Interactions in Pediatric Asthma Development N.W. Lukacs, PhD, Ann Arbor, MI 10:00 Relationships Between the Respiratory Microbiome and Asthma Phenotype Y.J. Huang, MD, Ann Arbor, MI 10:25 Opportunities for Microbial Intervention in Asthma F.D. Martinez, MD, Tucson, AZ BASIC • CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM D6 GENETIC AND MOLECULAR MECHANISMS OF ABNORMAL LUNG DEVELOPMENT Assemblies on Pediatrics; Critical Care; Pulmonary Circulation; Respiratory Cell and Molecular Biology 8:45 a.m. - 10:45 a.m. Target Audience Neonatologists, pediatric pulmonologists, geneticists, pathologists, respiratory therapists, and basic science researcher with interests in mechanisms of lung development Objectives At the conclusion of this session, the participant will be able to: • name the stages of lung development impacted by disorders such as acinar dysplasia and congenital alveolar dysplasia; • recognize the clinical phenotypes of infants with diffuse disorders of lung development and be able to better diagnose using molecular diagnostics; ATS 2020 • Philadelphia, PA WEDNESDAY • MAY 20 127